Jingrong Jean Cui, Chief Scientific Officer at Turning Point Therapeutics, Inc. (TPTX), sold 213,300 shares at $51.02 ($11.0M) on 2019-12-06, disclosed to the SEC on 2019-12-09.
Open-market sale of $11.0M TPTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.93 | 21,280 | $1.1M | 9.9% |
| 2 | $50.93 | 21,280 | $1.1M | 9.9% |
| 3 | $52.08 | 12,200 | $635K | 5.8% |
| 4 | $52.84 | 22,630 | $1.2M | 10.9% |
| 5 | $52.84 | 22,630 | $1.2M | 10.9% |
| 6 | $50.67 | 36,627 |
| $1.9M |
| 16.9% |
| 7 | $50.67 | 36,627 | $1.9M | 16.9% |
| 8 | $51.02 | 14,263 | $728K | 6.6% |
| 9 | $51.02 | 14,263 | $728K | 6.6% |
| 10 | $54.33 | 3,000 | $163K | 1.5% |
| 11 | $55.35 | 4,100 | $227K | 2.1% |
| 12 | $55.94 | 4,200 | $235K | 2.1% |
| 13 | $56.78 | 200 | $11K | 0.1% |
| Total | $51.56 avg | 213,300 | $11.0M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |